~~<i id='84133C6EF7'><strike id='84133C6EF7'><tt id='84133C6EF7'><pre id='84133C6EF7'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

author：Wikipedia 2025-09-06 01:59:41 - browse：56

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： How to improve immunocompromised access to mAb treatments

leisure time

knowledge

focus

leisure time

explore

focus

SpencerPlatt/GettyImagesBiohavenPharmaceuticalssaidWednesdaythatanewtypeofexperimentalmedicinereduce

WSS

H5N1 bird flu: what we're starting to learn about infection in cows

Do more moles mean more problems? Not so, says new study

Readout LOUD podcast: What to know about H5N1 bird flu

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Focused ultrasound for uterine fibroids: an uphill battle

explore

explore

leisure time

Hollywood unions extend contract negotiations for actors

Stigma and the return of syphilis

Wildfire smoke exposes gaps in outdoor worker protections

Lab trade group sues FDA to halt regulation of lab

Dobbs anniversary: the lost opportunity of abortion as health care

Researchers on aging grapple with how to calculate biological age

How one medical school became remarkably diverse

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Anesthesiologist group: stop taking Ozempic before surgery

Lab trade group sues FDA to halt regulation of lab

knowledge

Readout LOUD podcast: What to know about H5N1 bird flu

Heat waves linked to early deliveries, preterm births in new study

Lab trade group sues FDA to halt regulation of lab

Telehealth startups turn to complex chronic diseases

Apple Watch's A

Study: People of West African ancestry at greater risk of cardiac amyloidosis

focus

leisure time

explore

focus